PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 360 Huntington Avenue, 140 The Fenway Building, Boston, MA, 02115, USA. l.milane@northeastern.edu.\', \'Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 360 Huntington Avenue, 140 The Fenway Building, Boston, MA, 02115, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s13346-021-00911-y
?:doi
?:hasPublicationType
?:journal
  • Drug delivery and translational research
is ?:pmid of
?:pmid
?:pmid
  • 33512669
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.944
?:rankingScore_hIndex
  • 23
?:title
  • Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all